Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Special https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
-
Idli is an unarguably all-time favourite of Indians. Period! The steamed, puffy and easy to digest, South Indian dish has an interesting sto...
-
A day after Raj Thackeray's convoy was attacked with betel nuts, Maharashtra Navnirman Sena (MNS) workers hurled coconuts and cow dung a...
No comments:
Post a Comment